Regulation of Mitochondrial Transport and Inter-Microtubule Spacing by Tau Phosphorylation at the Sites Hyperphosphorylated in Alzheimer's Disease
Open accessAbstract
The microtubule-associated protein Tau is a major component of the neurofibrillary tangles that serve as a neuropathological hallmark of Alzheimer's disease. Tau is a substrate for protein phosphorylation at multiple sites and occurs in tangles in a hyperphosphorylated state. However, the physiological functions of Tau phosphorylation or how it may contribute mechanistically to Alzheimer's pathophysiology are not completely understood. Here, we examined the function of human Tau phosphorylation at three sites, Ser199, Ser202, and Thr205, which together comprise the AT8 sites that mark abnormal phosphorylation in Alzheimer's disease. Overexpression of wild-type Tau or mutated forms in which these sites had been changed to either unphosphorylatable alanines or phosphomimetic aspartates inhibited mitochondrial movement in the neurite processes of PC12 cells as well as the axons of mouse brain cortical neurons. However, the greatest effects on mitochondrial translocation were induced by phosphomimetic mutations. These mutations also caused expansion of the space between microtubules in cultured cells when membrane tension was reduced by disrupting actin filaments. Thus, Tau phosphorylation at the AT8 sites may have meaningful effects on mitochondrial movement, likely by controlling microtubule spacing. Hyperphosphorylation of the AT8 sites may contribute to axonal degeneration by disrupting mitochondrial transport in Alzheimer's disease.
AI snapshot
Written from the paper’s full text.
TL;DR
Tau phosphorylation at the Alzheimer’s disease–associated AT8 sites (Ser199/Ser202/Thr205) more strongly inhibits mitochondrial movement than wild-type or nonphosphorylatable Tau. The phosphomimetic Tau 3D also expands inter-microtubule spacing under reduced membrane tension, suggesting a mechanism linking AT8 phosphorylation to impaired axonal mitochondrial transport.
Key findings
- In NGF-treated PC12 cell neurites, the stationary mitochondrial fraction was 23.0% in controls, 47.6% with Tau WT, 44.1% with Tau 3A, and 61.3% with phosphomimetic Tau 3D.
- In cultured mouse cortical neuron axons, stationary mitochondria were 31.6% in controls, 48.5% with Tau WT, 46.6% with Tau 3A, and 64.4% with Tau 3D.
- In latrunculin B–treated Sf9 cell processes, mean inter-microtubule distances were 26.8 ± 2.7 nm for Tau WT, 27.2 ± 2.0 nm for Tau 3A, and 37.1 ± 2.3 nm for Tau 3D.
- Tau did not alter kinesin head-domain binding to microtubules in vitro, and in PC12 neurites Tau overexpression reduced inter-MT distances to ~33–34 nm without significant differences among WT, 3A, and 3D.
Methods
- The longest human Tau was mutated at Ser199, Ser202, and Thr205 to nonphosphorylatable alanines (3A) or phosphomimetic aspartates (3D); WT, 3A, and 3D were expressed in PC12 cells, mouse embryonic cortical neurons, COS-7 cells, and Sf9 cells.
- Mitochondrial movement was imaged with Mito-GFP at 5 s intervals over 300 s in PC12 neurites and cortical neuron axons; inter-MT distances were measured by electron microscopy, including Sf9 cells treated with latrunculin B to disrupt actin filaments.
- In vitro assays examined Tau phosphorylation by Cdk5-p25, Tau binding to microtubules, and kinesin motor-domain binding to microtubules; statistics used one-way ANOVA with Holm’s test and ANCOVA.
Limitations
- The paper states that untreated Sf9 cells formed only a small number of processes, so the number of inter-MT distances counted was not sufficient; latrunculin B was used to increase process formation.
- The paper notes that in matured or aged neurons, Tau may not be the only space-making protein affecting mitochondrial movement, and that neurofilament tail domains may also contribute; the phosphorylation-dependent tunnel-opening/closing idea is described as a working hypothesis to be explored further.
- Evident from the text: the study relies on cell-culture overexpression systems and phosphomimetic mutants rather than human AD tissue or in vivo models, so the 3D mutant may not fully replicate native phosphorylation effects.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
23 of 54 cited sources checked · 7 supported · 0 flagged · accuracy not yet measured
- Findingcitation
Cdk5 phosphorylates Tau at the sites recognized by AT8 (Ser199, Ser202, and Thr205).
“confirming that Cdk5 indeed phosphorylated the sites recognized by AT8 (Takahashi et al., 2003) and that these phosphorylation sites were disrupted in 3A and 3D constructs.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Takahashi et al., 2003 source
The Results and Discussion report that Cdk5 is involved in tau phosphorylation detected by AT-8, particularly at Ser-202 and Thr-205 during brain development. The Chemicals and Antibodies section defines AT-8 recognition by phosphorylation at those two sites, not Ser-199; our copy therefore does not support including Ser-199 among the AT-8-recognized sites. Page numbers were not available in our copy. (LLM, conf=0.90)
Experimental — accuracy not yet measured
- Premisecitation
Overexpression of Tau inhibits mitochondrial transport in various cells.
“Overexpression of Tau inhibits mitochondrial transport in various cells (Ebneth et al., 1998;Trinczek et al., 1999;Stamer et al., 2002;Dixit et al., 2008;Stoothoff et al., 2009;Vossel et al., 2010).”
Quote in the paperSubstantial claim2 of 3 sources checked - Findingcitation
Overexpression of Tau WT, 3A, or 3D reduced anterograde movement of mitochondria in PC12 cells and cortical neurons.
“Overexpression of either Tau WT, 3A, or 3D reduced anterograde movement of mitochondria in PC12 cells and cortical neurons, as reported (Mandelkow et al., 2004;Hollenbeck and Saxton, 2005;Dixit et al., 2008).”
Quote in the paperSubstantial claim1 of 3 sources checked- cites Mandelkow et al., 2004 source
The Results (Fig. 5; page unavailable) show that tau expression reduced anterograde mitochondrial movement in retinal ganglion cell axons, and Fig. 7 reports transport inhibition by a non-phosphorylatable tau mutant. The paper does not establish the stated effect for Tau 3D or in PC12 cells and cortical neurons; its experiments here use retinal ganglion cells and a KXGA mutant. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites Hollenbeck and Saxton, 2005 source
- cites Dixit et al., 2008 source
- Premisecitation
Tau overexpression inhibits mitochondrial movement in various cell types.
“Tau overexpression inhibits mitochondrial movement in various cell types (Ebneth et al., 1998;Trinczek et al., 1999;Stamer et al., 2002;Dixit et al., 2008;Stoothoff et al., 2009;Vossel et al., 2010).”
Quote in the paperSubstantial claim2 of 3 sources checked - Interpretationreasoning
Limited spacing between MTs may block mitochondrial movement in neuritic processes such as axons and dendrites.
“Considering that mitochondria would be transported within MT bundles in cultured neurons (Yu and Baas, 1994;Rochlin et al., 1996), limited spacing between MTs may block mitochondrial movement in neuritic processes such as axon and dendrites.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites Yu and Baas, 1994 source
- cites Rochlin et al., 1996 source
The Additional information section says microtubules could provide a scaffold along which endoplasmic reticulum and other axoplasmic elements advance. It does not specifically describe mitochondrial transport within microtubule bundles. The suggestion that limited spacing may block movement is the citing authors’ inference, not a finding attributed to this source. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Premisecitation
When Ser199/Ser202/Thr205 sites are phosphorylated, the N-terminal domain swings away from the C-terminal domain, resulting in a conformation that extends from the MT wall.
“When the Ser199/Ser202/Thr205 sites are phosphorylated the N-terminal domain swings away from the C-terminal domain, resulting in a conformation that extends from the MT wall (Jeganathan et al., 2008).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Jeganathan et al., 2008 source
The Results passage on the AT8* mutant (page unavailable) reports that mimicking phosphorylation at Ser199, Ser202, and Thr205 makes the N-terminal domain swing away from the C-terminal domain. The paper used phosphomimetic mutations rather than directly phosphorylating those sites. It separately states that Tau’s N-terminal domain projects away from the microtubule surface, but does not establish that AT8* produces a conformation extending from the microtubule wall. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Interpretationcitation
The axoplasmic MT milieu is under strong tension.
“These features may indicate that the axoplasmic MT milieu is under the strong tension (Yu and Baas, 1994;Rochlin et al., 1996).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites Yu and Baas, 1994 source
The Results and Discussion describe closely spaced, parallel axonal microtubules, but do not say that the axoplasmic microtubule milieu is under strong tension. Searches for tension and mechanical stress found no passage addressing that claim; page numbers were not available in our copy. (LLM, conf=0.74)
Experimental — accuracy not yet measured - cites Rochlin et al., 1996 source
The Microtubules section discusses microtubule stability and assembly kinetics, and the Results describe the shape of microtubules in growth cones. Neither passage addresses whether the axoplasmic microtubule milieu is under strong mechanical tension. Searches for tension, tensile stress, and related mechanical terms found no passage establishing that point. (LLM, conf=0.70)
Experimental — accuracy not yet measured
- Premisecitation
Impairment of mitochondrial traffic is a feature of tauopathies.
“Impairment of mitochondrial traffic is also a feature of tauopathies (Stokin et al., 2005;Lippens et al., 2007).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites Stokin et al., 2005
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Lippens et al., 2007 source
A passage labeled Abstract (page unavailable) says that tau deregulation can cause defects in axonal transport in Alzheimer’s disease and discusses transport of organelles. It does not specifically identify impaired mitochondrial traffic, so it supports the broader transport point but not the claim’s mitochondrial specificity. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Findingcitation
Tau WT overexpression increased the pausing frequency from 31.6 to 48.5% in neurons.
“Tau WT overexpression increased the pausing frequency from 31.6 to 48.5% in neurons, which is almost identical to previous results (Stamer et al., 2002).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Stamer et al., 2002 source
- Findingown data
Phosphomimetic mutations at the AT8 sites (Tau 3D) induced the greatest effects on mitochondrial translocation compared with wild-type Tau and Tau 3A.
“However, the greatest effects on mitochondrial translocation were induced by phosphomimetic mutations.”
- Also stated in: § Tau phosphorylation reduces mitochondrial motility in neuritic processes of PC12 cells · hedged
“Moving mitochondria in neurites overexpressing Tau 3D were significantly fewer than those in Tau WT or 3A-expressing neurites, indicating the stronger inhibitory activity of Tau 3D.”
Quote in the paperSubstantial claim - Also stated in: § Tau phosphorylation reduces mitochondrial motility in neuritic processes of PC12 cells · hedged
- Findingown data
Tau phosphorylation at the AT8 sites does not inhibit the binding of Tau to microtubules in cells.
“suggesting that Tau phosphorylation at the AT8 sites does not inhibit the binding of Tau to MTs in cells, as reported previously (Rankin et al., 2005;Hanger et al., 2009).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Rankin et al., 2005 source
- cites Hanger et al., 2009
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingown data
In PC12 neurites, Tau 3D had significantly fewer moving mitochondria than Tau WT or Tau 3A.
“Moving mitochondria in neurites overexpressing Tau 3D were significantly fewer than those in Tau WT or 3A-expressing neurites, indicating the stronger inhibitory activity of Tau 3D.”
Quote in the paperSubstantial claim - Findingown data
Overexpression of wild-type Tau or mutated forms in which the AT8 sites were changed to unphosphorylatable alanines or phosphomimetic aspartates inhibited mitochondrial movement in neurite processes of PC12 cells and axons of mouse brain cortical neurons.
“Overexpression of wild-type Tau or mutated forms in which these sites had been changed to either unphosphorylatable alanines or phosphomimetic aspartates inhibited mitochondrial movement in the neurite processes of PC12 cells as well as the axons of mouse brain cortical neurons.”
- Also stated in: § Tau phosphorylation reduces mitochondrial motility in neuritic processes of PC12 cells · plain
“The number of motile mitochondria was higher in control PC12 cells compared with Tau-overexpressing cells.”
Quote in the paperSubstantial claim - Also stated in: § Tau phosphorylation reduces mitochondrial motility in neuritic processes of PC12 cells · plain
- Findingown data
Tau 3D caused expansion of the space between microtubules in cultured cells when membrane tension was reduced by disrupting actin filaments.
“These mutations also caused expansion of the space between microtubules in cultured cells when membrane tension was reduced by disrupting actin filaments.”
- Also stated in: § The phosphorylation mimic Tau 3D increases MT spacing in processes of Sf9 cells · plain
“The inter-MT distances were greater in Tau 3Doverexpressing cells compared to those overexpressing WT or 3A (Fig. 7L).”
Quote in the paperSubstantial claim - Also stated in: § The phosphorylation mimic Tau 3D increases MT spacing in processes of Sf9 cells · plain
- Findingown data
Overexpression of each Tau construct specifically decreased anterograde movement of mitochondria in PC12 cells.
“Overexpression of each Tau construct specifically decreased the anterograde movement of mitochondria (compare control with WT/3A/3D in Fig. 4C).”
Quote in the paperSubstantial claim - Findingown data
Tau 3D mimics phosphorylation at the AT8 sites.
“The results indicated that Tau 3D in fact mimics phosphorylation at the AT8 sites.”
Quote in the paperSubstantial claim - Findingown data
Tau WT is phosphorylated at the AT8 recognition sites in COS-7 cells.
“Immunodetection of Tau WT but not 3A nor 3D clearly demonstrated that Tau WT was phosphorylated at the AT8 recognition sites in COS-7 cells (Fig. 1C, middle).”
Quote in the paperSubstantial claim - Findingown data
Recombinant pure Tau 3A and 3D bound to microtubules similarly to Tau WT in vitro.
“Furthermore, in vitro studies indicated that both recombinant pure Tau 3A and 3D bound to MTs similarly to Tau WT (data not shown).”
Quote in the paperSubstantial claim - Findingown data
Neither Tau 3D nor Tau 3A had a further preferential effect on the direction of mitochondrial movement in PC12 cells.
“However, neither Tau 3D nor 3A had further preferential effect on the direction of mitochondrial movement (Fig. 4).”
Quote in the paperSubstantial claim - Findingown data
Tau 3D had a second peak of mitochondrial movement with a velocity of approximately 0.4-0.6 μm/s, particularly in the anterograde direction, in PC12 cells.
“Notably, for Tau 3D there was a second peak of mitochondrial movement with a velocity of ϳ0.4 -0.6 m/s, particularly in the anterograde direction.”
Quote in the paperSubstantial claim - Findingown data
In PC12 neurites, there was no significant difference in inter-microtubule distances among Tau WT, Tau 3A, and Tau 3D overexpression.
“In contrast, there was no significant difference in the inter-MT distances among Tau WT, 3A, and 3D overexpression (Fig. 8 B).”
Quote in the paperSubstantial claim - Findingown data
Tau overexpression reduced the velocity of mitochondrial movement in PC12 cells.
“Tau overexpression shifted the peak to Ͻ0.1 m/s.”
- Also stated in: § Tau phosphorylation reduces mitochondrial motility in neuritic processes of PC12 cells · plain
“The mean velocities for anterograde and retrograde movement were reduced to 0.19 Ϯ 0.056 and 0.17 Ϯ 0.035 m/s by Tau WT overexpression, 0.20 Ϯ 0.02 and 0.17 Ϯ 0.07 m/s by Tau 3A overexpression, and 0.22 Ϯ 0.06 and 0.18 Ϯ 0.04 m/s by Tau 3D overexpression, respectively.”
Quote in the paperSubstantial claim - Also stated in: § Tau phosphorylation reduces mitochondrial motility in neuritic processes of PC12 cells · plain
- Findingown data
In untreated Sf9 cells, there was no significant difference in inter-microtubule distances between cells infected with Tau WT, Tau 3A, or Tau 3D.
“Of the 85 inter-MT distances measured, there was no significant difference between cells infected with the various Tau proteins (Fig. 7H).”
Quote in the paperSubstantial claim - Findingown data
Phosphorylation at the AT8 sites of Tau WT, but not 3A or 3D, occurs in COS-7 cells.
“Phosphorylation at the AT8 sites of Tau WT, but not 3A or 3D, in COS-7 cells.”
Quote in the paperSubstantial claim - Findingown data
In cortical neuron axons, Tau 3D induced significantly higher stationary phase than Tau WT and Tau 3A.
“The stational phase induced by Tau 3D was significantly higher than those induced by Tau WT and 3A, indicating that Tau 3D has stronger inhibitory activity against mitochondrial movement.”
Quote in the paperSubstantial claim - Findingown data
Cdk5-dependent in vitro phosphorylation occurs at the AT8 sites of Tau WT, but not Tau 3A or 3D.
“Cdk5-dependent in vitro phosphorylation at the AT8 sites of Tau WT, but not Tau 3A or 3D.”
Quote in the paperSubstantial claim - Findingown data
Increasing amounts of Tau WT, Tau 3A, or Tau 3D did not alter the binding of kinesin RK430 to microtubules.
“Increasing the amount of Tau WT or Tau mutants did not alter the binding of RK430 kinesin-His to MTs even though excess Tau was added such that unbound Tau appeared in the supernatant.”
Quote in the paperSubstantial claim - Findingown data
Using the phosphorylation mimic Tau 3D, the authors showed that Tau phosphorylation within the AT8 sites inhibited mitochondrial transport more effectively than Tau WT and Tau 3A.
“Using the phosphorylation mimic Tau 3D, we showed that Tau phosphorylation within the AT8 sites inhibited mitochondrial transport more effectively than in experiments carried out with Tau WT and Tau 3A.”
Quote in the paperSubstantial claim - Findingown data
Tau WT, 3A, and 3D colocalize to MTs in COS-7 cells.
“Colocalization of Tau WT, 3A, or 3D to MTs in COS-7 cells.”
Quote in the paperNot a substantial claim - Findingown data
Neurons expressing Tau 3D had a small proportion of mitochondria moving at approximately 0.5-0.6 μm/s, particularly anterograde, whereas neurons expressing Tau WT or Tau 3A did not.
“As in PC12 cells, neurons expressing Tau 3D had a small proportion of mitochondria that moved at ϳ0.5-0.6 m/s, particularly in the anterograde direction, whereas neurons expressing Tau WT or 3A did not.”
Quote in the paperNot a substantial claim - Findingown data
Tau 3D more potently inhibited mitochondrial transport than Tau WT or Tau 3A.
“We found that Tau 3D more potently inhibited mitochondrial transport than Tau WT or Tau 3A.”
Quote in the paperSubstantial claim - Findingown data
Tau does not inhibit the binding of kinesin to MTs.
“Tau does not inhibit the binding of kinesin to MTs.”
Quote in the paperSubstantial claim - Findingown data
Sf9 cells overexpressing Tau 3D formed longer and wider processes compared to those expressing Tau WT or 3A.
“Sf9 cells overexpressing Tau 3D formed longer and wider processes compared to those expressing Tau WT or 3A.”
Quote in the paperSubstantial claim - Findingown data
Tau 3D takes a conformation similar to phosphorylated Tau WT.
“Tau 3D takes conformation similar to phosphorylated Tau WT.”
Quote in the paperSubstantial claim - Findingown data
In PC12 neurites, inter-microtubule distances were reduced in Tau-expressing processes compared with control untransfected processes (~35 nm vs ~45 nm).
“The inter-MT distances were reduced to ϳ35 nm in Tauexpressing processes from ϳ45 nm in the control untransfected processes (Fig. 8 B).”
Quote in the paperSubstantial claim - Findingown data
The authors observed inhibition of mitochondrial movement in PC12 cells and cortical neurons.
“We also observed an inhibition of mitochondrial movement in PC12 cells and cortical neurons.”
Quote in the paperSubstantial claim - Findingown data
The velocity of mitochondria was reduced similarly in both directions by Tau overexpression regardless of phosphorylation state.
“Furthermore, the velocity was reduced similarly in both directions by Tau overexpression regardless of its phosphorylation state, although the inhibition profile differed slightly among the three Tau constructs.”
Quote in the paperSubstantial claim - Findingown data
In Sf9 cell processes treated with latrunculin B, the inter-MT distance in MT bundles containing Tau 3D was longer than in bundles containing Tau WT or Tau 3A.
“By observing MT bundles in Sf9 cell processes treated with latrunculin B, we found that the inter-MT distance in MT bundles containing Tau 3D was longer than that in MT bundles containing Tau WT or Tau 3A.”
- Also stated in: § Discussion · plain
“The mean distance was 26.8 Ϯ 2.7 nm for Tau WT (n ϭ 60), 27.2 Ϯ 2.0 nm for Tau 3A (n ϭ 80), and 37.1 Ϯ 2.3 nm for Tau 3D (n ϭ 75).”
Quote in the paperSubstantial claim - Also stated in: § Discussion · plain
- Findingown data
The effect of Tau on mitochondrial movement was dependent on the amount of Tau plasmid used for transfection.
“The effect of Tau on mitochondrial movement was dependent on the amount of Tau plasmid used for transfection.”
Quote in the paperNot a substantial claim - Findingown data
In latrunculin B-treated Sf9 cells, Tau 3D-expressing cells had larger and longer processes than cells expressing Tau WT or Tau 3A.
“Sf9 cells expressing Tau 3D had larger and longer processes than cells expressing Tau WT or 3A (Fig. 7M-O).”
Quote in the paperSubstantial claim - Findingreasoning
Phosphorylation-dependent expansion of the space between MTs was observed only with reduced membrane tension.
“Phosphorylation-dependent expansion of the space between MTs was observed only with reduced membrane tension.”
Quote in the paperSubstantial claim - Interpretationreasoning
Hyperphosphorylation of the AT8 sites may contribute to axonal degeneration by disrupting mitochondrial transport in Alzheimer's disease.
“Hyperphosphorylation of the AT8 sites may contribute to axonal degeneration by disrupting mitochondrial transport in Alzheimer's disease.”
Quote in the paperSubstantial claim- Rests on an assumption: Findings from cultured cells and overexpression of Tau mutants generalize to Alzheimer's disease pathophysiology.
- Rests on an assumption: Disrupted mitochondrial transport causes axonal degeneration.
- Interpretationown data
Phosphorylation at the AT8 sites does not affect the direction of mitochondrial movements.
“indicating that phosphorylation at the AT8 sites does not affect the direction of mitochondrial movements.”
Quote in the paperSubstantial claim - Interpretationown data
The reduced mitochondrial movement caused by Tau 3D was not caused by inhibiting the interaction between the kinesin head domain and microtubules.
“Thus, the reduced mitochondrial movement was not caused by inhibiting the interaction between the kinesin head domain and MTs.”
Quote in the paperSubstantial claim - Premisecitation
Tau is a space-making protein between microtubules.
“Tau is a space-making protein between MTs (Chen et al., 1992;Frappier et al., 1994;Marx et al., 2000).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Chen et al., 1992
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Frappier et al., 1994 source
- cites Marx et al., 2000
- Interpretationown data
Phosphorylation of Tau at the AT8 sites has an additional inhibitory action on mitochondrial movement over the Tau molecule itself.
“Phosphorylation of Tau at the AT8 sites has an additional inhibitory action on mitochondrial movement over the Tau molecule itself.”
Quote in the paperSubstantial claim - Premisecitation
Neurofilaments are highly phosphorylated in aged axons and AD neurodegenerative disease.
“NFs are highly phosphorylated in aged axons and AD neurodegenerative disease (Uchida et al., 2004;Rudrabhatla et al., 2010).”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationreasoning
Mitochondrial movements in aged and neurodegenerative axons would be affected in a more complicated manner.
“Thus, mitochondrial movements in aged and neurodegenerative axons would be affected in a more complicated manner.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The observed effect of Tau 3D on mitochondrial transport is likely caused by phosphorylation at Ser199/Ser202/Thr205.
“Because Tau 3A and 3D have similar phosphorylation profiles at other sites, the observed effect is likely caused by phosphorylation at Ser199/Ser202/Thr205.”
Quote in the paperSubstantial claim - Interpretationreasoning
The authors' observation is consistent with the model that distance between MTs mediates Tau-mediated inhibition of mitochondrial transport.
“Our observation is consistent with the last model described above.”
Quote in the paperSubstantial claim - Interpretationown data
Tau inhibits mitochondrial transport independent of its phosphorylation state.
“Thus, Tau clearly inhibits mitochondrial transport independent of its phosphorylation state.”
Quote in the paperSubstantial claim - Interpretationreasoning
Under reduced membrane tension, phosphorylation of Tau at the AT8 sites increases the space between microtubules.
“Because latrunculin B reduces membrane tension by depolymerizing submembranous actin filaments, these results suggested that, under reduced tension, phosphorylation of Tau at the AT8 sites increases the space between MTs.”
Quote in the paperSubstantial claim
- May combine two claims. 30
- Classified as probably not a substantial claim. 12
- The quote only partly states this claim. 5
May combine two claims.
InterpretationcitationHyperphosphorylation of the tail domains would increase the inter-NF distances to expand the NF domain in axons, giving higher pressure to the MT domain.
“Hyperphosphorylation of the tail domains would increase the inter-NF distances to expand the NF domain in axons (Kumar et al., 2002;Kanungo et al., 2011), giving higher pressure to the MT domain.”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites Kumar et al., 2002 source
The Discussion reports that increased sidearm phosphorylation expands the sidearm brush and regulates spacing between neurofilaments. It does not establish that this expands a distinct NF domain in the axon. The subsequent suggestion of higher pressure on the MT domain is not addressed by the paper and appears to be the citing authors’ inference. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites Kanungo et al., 2011
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationHyperphosphorylation of Tau is linked to neurodegeneration, with phosphorylation of more than 20 sites shown in degenerated brains of Alzheimer's patients.
“However, hyperphosphorylation is linked to neurodegeneration with phosphorylation of more than 20 sites shown in the degenerated brains of Alzheimer's patients (Watanabe et al., 1993;Morishima-Kawashima et al., 1995;Stoothoff and Johnson, 2005).”
Quote in the paperSubstantial claim1 of 3 sources checked- cites Watanabe et al., 1993 source
- cites Morishima-Kawashima et al., 1995 source
The opening section reports abnormal phosphorylation of PHF-tau in Alzheimer’s disease and identifies 19 sites, not more than 20. It also describes neurofibrillary tangles as closely related to neuronal loss, while the Discussion presents a link between abnormal tau phosphorylation and neuronal degeneration as a possibility rather than an established finding. (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites Stoothoff and Johnson, 2005
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDetection by AT8 is commonly used as a marker of abnormal phosphorylation in brains of Alzheimer's patients.
“their detection by this antibody is commonly used as a marker of abnormal phosphorylation in brains of Alzheimer's patients.”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites Goedert et al., 1995 source
- cites Wang et al., 2006 source
The Abstract links Alzheimer’s disease to tau hyperphosphorylation, but it does not identify AT8 or describe its use as a marker in patients’ brains. Searches for AT8 and for antibody-based detection found no passage addressing that point. (LLM, conf=0.74)
Experimental — accuracy not yet measured - cites Hanger et al., 2009 source
May combine two claims.
PremisecitationPhosphorylation at the AT8 sites may extend the projection domain outwards from the surface of microtubules and affect mitochondrial transport.
“Phosphorylation at these sites may extend the projection domain outwards from the surface of MTs (Jeganathan et al., 2008) and affect mitochondrial transport (Mukhopadhyay and Hoh, 2001;Jeganathan et al., 2008;Shahpasand et al., 2008).”
Quote in the paperSubstantial claim2 of 3 sources checked- cites Jeganathan et al., 2008 source
The Results passage (Fig. 2C–D; page unavailable) reports that an AT8 phosphorylation mimic makes tau’s N-terminal domain swing away from its C-terminal domain. The introductory passage says the N-terminal domain projects away from the microtubule surface, but the study does not show that AT8 phosphorylation extends it farther from that surface. It discusses microtubule-based organelle transport generally, not an effect on mitochondrial transport. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites Mukhopadhyay and Hoh, 2001 source
The citation to Mukhopadhyay and Hoh is attached to the mitochondrial-transport clause. In Results and discussion (page unavailable), the paper says MAPs may regulate motor-protein interactions and reports that tau affects motor attachment and detachment, but not transport speed. It does not address mitochondrial transport or link phosphorylation at AT8 sites to a transport effect. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites Shahpasand et al., 2008 source
May combine two claims.
PremisecitationThe AT8 sites (Ser199/Ser202/Thr205) are physiological phosphorylation sites and markers of hyperphosphorylation in Alzheimer's disease.
“The AT8 sites are not only physiological phosphorylation sites (Kimura et al., 2007;Verwer et al., 2007) but also markers of hyperphosphorylation in Alzheimer's disease (Plattner et al., 2006).”
Quote in the paperSubstantial claim2 of 3 sources checked- cites Kimura et al., 2007 source
The Results section (page unavailable) reports AT8 phosphorylation in both adult and aged mice expressing wild-type human tau, without an age-related increase. This supports the narrower point that AT8 phosphorylation can occur without age-related hyperphosphorylation, but the study does not establish that the sites are physiological in normal animals; it also identifies the AT8 sites as Ser202 and Ser205, not Ser199/Ser202/Thr205. The Alzheimer's disease marker claim is attributed to Plattner et al., not Kimura et al., in the citing sentence. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites Verwer et al., 2007 source
- cites Plattner et al., 2006 source
May combine two claims.
PremisecitationThe AT8 sites are physiological sites for phosphorylation, but they are not always phosphorylated.
“The AT8 sites are physiological sites for phosphorylation, but they are not always phosphorylated (Kimura et al., 2007;Verwer et al., 2007).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites Kimura et al., 2007 source
The section on PHF1-site phosphorylation identifies AT8 as recognizing tau phosphorylated at Ser202 and Ser205, and reports AT8 immunoreactivity in the studied mice. The Discussion says AT8-site phosphorylation did not increase with aging in those mice, but it does not establish that phosphorylation at these sites is physiological or that the sites are sometimes unphosphorylated. (LLM, conf=0.78)
Experimental — accuracy not yet measured - cites Verwer et al., 2007 source
May combine two claims.
PremisecitationThe C-terminal tail domains of neurofilament M and H subunits extrude outward from core filaments, as does the projection domain of Tau, to make spaces between neurofilaments.
“The C-terminal tail domains of neurofilament M and H subunits extrude outward from core filaments, as does the projection domain of Tau, to make spaces between neurofilaments (NFs) (Hisanaga and Hirokawa, 1989).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Hisanaga and Hirokawa, 1989 source
The section “Structure of the projections of control and dephosphorylated NFs” (page unavailable) describes projections extending from NF core filaments, and the Discussion describes cross-bridges between NFs that seem to comprise NF-H and NF-M tail domains. The copy does not discuss Tau’s projection domain or establish that these projections create the spaces between neurofilaments. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationWhen Tau is overexpressed in cortical neurons, tubulin synthesis is upregulated and MTs become more numerous and densely packed, resulting in inhibition of mitochondrial movement.
“When Tau is overexpressed in cortical neurons, tubulin synthesis is upregulated and MTs become more numerous and densely packed, resulting in inhibition of mitochondrial movement.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Thies and Mandelkow, 2007 source
The Microtubule bundling section reports increased tubulin production and denser, more numerous microtubules after tau transfection; the mitochondrial-movement section reports strongly inhibited movement. However, Materials and Methods identifies the cells as hippocampal, not cortical, neurons, and the Discussion describes increased microtubule density and bundling as a possible contributor to the transport defect rather than its established sole cause. Page numbers were not available in our copy. (LLM, conf=0.90)
Experimental — accuracy not yet measured
May combine two claims.
Findingown dataTau 3A and 3D constructs are not phosphorylated at the AT8 sites.
“Phosphorylated Tau WT was immunoreactive to AT8, whereas phosphorylated Tau 3A and 3D were not (Fig. 1 B)”
- Also stated in: § Phosphorylation of Tau mutants and their binding to MTs · boosted
“Immunodetection of Tau WT but not 3A nor 3D clearly demonstrated that Tau WT was phosphorylated at the AT8 recognition sites in COS-7 cells (Fig. 1C, middle).”
Quote in the paperSubstantial claim- Also stated in: § Phosphorylation of Tau mutants and their binding to MTs · boosted
May combine two claims.
Findingown dataIn PC12 cells, the stationary phase of mitochondria was 23.0% in control, 47.6% in Tau WT, 44.1% in Tau 3A, and 61.3% in Tau 3D.
“The ratio of stationary phase was 23.0% in control PC12 cells but 47.6% in cells expressing Tau WT and 44.1% for 3A; for 3D, however, the percentage was higher still, 61.3% (Fig. 4B).”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataExpression levels of Tau WT, 3A, and 3D were almost similar in PC12 cells and cultured neurons when 2.5 μg plasmids were used.
“Expression levels were almost similar among Tau WT, 3A, and 3D constructs (Fig. 3 B, C).”
- Also stated in: § Expression of Tau constructs in PC12 cells and cultured cortical neurons · plain
“When 2.5 g of plasmids were used, the fluorescent intensities were ϳ1.7 and ϳ1.5 fold of untransfected PC12 cells (Fig. 3B) and cultured neurons (Fig. 3C), respectively.”
Quote in the paperSubstantial claim- Also stated in: § Expression of Tau constructs in PC12 cells and cultured cortical neurons · plain
May combine two claims.
Findingown dataThe inter-MT distance was the same (15-25 nm) in MT bundles formed by Tau WT, 3A, and 3D in Sf9 cell processes, but it was expanded to 35-45 nm in processes expressing Tau 3D when actin filaments were disrupted by latrunculin B.
“The inter-MT distance was the same (15-25 nm) in MT bundles formed by Tau WT, 3A, and 3D in Sf9 cell processes, but it was expanded to 35-45 nm in processes expressing Tau 3D when actin filaments were disrupted by latrunculin B.”
- Also stated in: § Discussion · plain
“The mean distance was 15.7 Ϯ 2.2 nm for Tau WT (n ϭ 30), 17.5 Ϯ 2.7 nm for Tau 3A (n ϭ 27), and 16.3 Ϯ 2.2 nm for Tau 3D (n ϭ 28).”
- Also stated in: § Discussion · plain
“The mean distance was 26.8 Ϯ 2.7 nm for Tau WT (n ϭ 60), 27.2 Ϯ 2.0 nm for Tau 3A (n ϭ 80), and 37.1 Ϯ 2.3 nm for Tau 3D (n ϭ 75).”
Quote in the paperSubstantial claim- Also stated in: § Discussion · plain
The quote only partly states this claim.
Findingown dataThe ratio of mitochondria moving anterogradely and retrogradely was not different among Tau WT, Tau 3A, and Tau 3D in cortical neurons.
“However, the ratio of mitochondria moving anterogradely and retrogradely was not different among three Tau constructs, indicating that phosphorylation at the AT8 sites does not affect the direction of mitochondrial movements.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn cortical neuron axons, the stationary phase of mitochondria was 31.6% in control, 48.5% in Tau WT, 46.6% in Tau 3A, and 64.4% in Tau 3D.
“The duration of stationary phase was 31.6% in control neurons, which was higher than that observed in PC12 cells, consistent with a previous report (Morel et al., 2010).A significant increase in stationary phase was observed after transfection with Tau WT (48.5%) or 3A (46.6%); however, a higher stationary state (64.4%) was caused by Tau 3D (Fig. 5B).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Morel et al., 2010 source
May combine two claims.
Findingown dataIn vitro MT pellets, the mean inter-MT distance was 11.7 ± 1.7 nm for Tau WT, 11.8 ± 2.1 nm for Tau 3A, and 11.9 ± 1.6 nm for Tau 3D.
“The mean distance was 11.7 Ϯ 1.7 nm for Tau WT (n ϭ 48), 11.8 Ϯ 2.1 nm for Tau 3A (n ϭ 51), and 11.9 Ϯ 1.6 nm for Tau 3D (n ϭ 69).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTransfection with less than 2 μg Tau plasmid did not significantly affect mitochondrial movement, while more than 3 μg had a substantial and similar effect for all Tau constructs.
“While transfection with less than 2 g did not significantly affect mitochondrial movement, more than 3 g had a substantial (and similar) effect for all Tau constructs (data not shown).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe ratio of anterogradely moving duration to total moving period was significantly different between control and Tau-overexpressing neurons (p < 0.01) but not different between the three Tau constructs (p = 0.55).
“The ratio was significantly different between control and Tau-overexpressing neurons (p Ͻ 0.01) but was not different between three Tau constructs(pϭ0.55).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTau overexpression increased the number of MTs and reduced the inter-MT spaces in neurites of PC12 cells.
“We observed here that Tau overexpression increased the number of MTs and reduced the inter-MT spaces in neurites of PC12 cells.”
- Also stated in: § Discussion · plain
“The mean distance was 45.1 Ϯ 2.2 (n ϭ 54) for control PC12 cells and 33.1 Ϯ 2.4 nm (n ϭ 49), 34.1 Ϯ 2.6 nm (n ϭ 44), and 34.19 Ϯ 2.8 nm (n ϭ 62) for PC12 cells overexpressing Tau WT, 3A, and 3D, respectively.”
Quote in the paperSubstantial claim- Also stated in: § Discussion · plain
Probably not a substantial claim: may not pass S4 (based).
Findingnone givenTau 3A and 3D have similar phosphorylation profiles at other sites.
“Because Tau 3A and 3D have similar phosphorylation profiles at other sites”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn PC12 cell neurites, the mean inter-MT distance was 45.1 ± 2.2 nm for control and 33.1 ± 2.4 nm, 34.1 ± 2.6 nm, and 34.19 ± 2.8 nm for Tau WT, 3A, and 3D, respectively.
“The mean distance was 45.1 Ϯ 2.2 (n ϭ 54) for control PC12 cells and 33.1 Ϯ 2.4 nm (n ϭ 49), 34.1 Ϯ 2.6 nm (n ϭ 44), and 34.19 Ϯ 2.8 nm (n ϭ 62) for PC12 cells overexpressing Tau WT, 3A, and 3D, respectively.”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataIn latrunculin B-treated Sf9 cells, inter-microtubule distances were greater in Tau 3D-expressing cells than in Tau WT- or Tau 3A-expressing cells (mean 37.1 nm vs 26.8 and 27.2 nm).
“The inter-MT distances were greater in Tau 3Doverexpressing cells compared to those overexpressing WT or 3A (Fig. 7L).”
- Also stated in: § The phosphorylation mimic Tau 3D increases MT spacing in processes of Sf9 cells · plain
“that range was 35-45 nm in Tau 3D-expressing cells (mean distance ϭ 37.1 Ϯ 2.3 nm)”
Quote in the paperSubstantial claim- Also stated in: § The phosphorylation mimic Tau 3D increases MT spacing in processes of Sf9 cells · plain
The quote only partly states this claim.
Findingown dataTau overexpression reduced the velocity of mitochondria in axons of cortical neurons.
“Tau overexpression also reduced the velocity of mitochondria in axons.”
- Also stated in: § Tau phosphorylation reduces mitochondrial motility in neuritic processes of PC12 cells · plain
“The mean anterograde and retrograde velocities were 0.55 Ϯ 0.08 and 0.45 Ϯ 0.03 m/s, respectively, in control cells, but they were reduced to 0.17 Ϯ 0.03 and 0.18 Ϯ 0.06 m/s in Tau WT-overexpressing neurons, 0.18 Ϯ 0.03 and 0.19 Ϯ 0.07 m/s in Tau 3A-overexpressing neurons, and 0.18 Ϯ 0.03 and 0.18 Ϯ 0.04 m/s in Tau 3Doverexpressing neurons.”
Quote in the paperSubstantial claim- Also stated in: § Tau phosphorylation reduces mitochondrial motility in neuritic processes of PC12 cells · plain
Probably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing). The quote only partly states this claim.
Findingown dataIn cortical neurons, velocities faster than 1 μm/s were not observed in any Tau-overexpressing neurons.
“Velocities faster than 1 m/s, which accounted for 15 and 11% of anterograde and retrograde movements, respectively, in control neurons, were not observed in any Tau-overexpressing neurons.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn vitro, inter-microtubule distances in microtubule pellets polymerized with Tau WT, 3A, and 3D were typically less than 10 nm, indicating that the phosphorylation-mimicking mutation at AT8 did not affect inter-microtubule spacing in pelleted microtubules.
“The distances were typically Ͻ10 nm in the MT pellets polymerized with Tau WT, 3A, and 3D (Fig. 7D), indicating that the phosphorylationmimicking mutation at Ser199/Ser202/Thr205 did not affect the inter-MT spacing in pelleted MTs.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn untreated Sf9 cell processes, the mean inter-MT distance was 15.7 ± 2.2 nm for Tau WT, 17.5 ± 2.7 nm for Tau 3A, and 16.3 ± 2.2 nm for Tau 3D.
“The mean distance was 15.7 Ϯ 2.2 nm for Tau WT (n ϭ 30), 17.5 Ϯ 2.7 nm for Tau 3A (n ϭ 27), and 16.3 Ϯ 2.2 nm for Tau 3D (n ϭ 28).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPhosphorylated Tau 3A and 3D had similar, but not identical, banding patterns, suggesting that these mutants underwent similar phosphorylation at other sites.
“Phosphorylated Tau 3A and 3D had similar, but not identical, banding patterns, suggesting that these mutants underwent similar phosphorylation at other sites (Fig. 1 D).”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningTau WT had a higher level of phosphorylation than Tau 3A, including at the AT8 site.
“As a whole, the decreased mobility of Tau WT compared to Tau 3A indicated the higher level of phosphorylation of Tau WT, including the AT8 site.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe ratio of anterogradely moving time to total moving duration was significantly different between control and Tau-overexpressing PC12 cells (p < 0.01), but not significant between the three Tau constructs (p = 0.75).
“The ratio was significantly different between control and Tau-overexpressing PC12 cells (*p Ͻ 0.01), but was not significant between three Tau constructs ( p ϭ 0.75).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn latrunculin B-treated Sf9 cell processes, the mean inter-MT distance was 26.8 ± 2.7 nm for Tau WT, 27.2 ± 2.0 nm for Tau 3A, and 37.1 ± 2.3 nm for Tau 3D.
“The mean distance was 26.8 Ϯ 2.7 nm for Tau WT (n ϭ 60), 27.2 Ϯ 2.0 nm for Tau 3A (n ϭ 80), and 37.1 Ϯ 2.3 nm for Tau 3D (n ϭ 75).”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataTau phosphorylation at the AT8 sites may have meaningful effects on mitochondrial movement, likely by controlling microtubule spacing.
“Thus, Tau phosphorylation at the AT8 sites may have meaningful effects on mitochondrial movement, likely by controlling microtubule spacing.”
- Also stated in: § Discussion · hedged
“we would like to propose that phosphorylation of Tau at the AT8 sites affects the transport of mitochondria along MTs by changing the inter-MT spaces.”
Quote in the paperSubstantial claim- Rests on an assumption: Increased inter-microtubule spacing impairs mitochondrial transport.
- Also stated in: § Discussion · hedged
May combine two claims.
PremisecitationAT8 recognizes Tau phosphorylated at Ser202 and Thr205 or at Ser199, Ser202, and Thr205.
“AT8, which recognizes Tau that is phosphorylated at Ser202 and Thr205 (Goedert et al., 1995) or Ser199, Ser202, and Thr205 (Hanger et al., 2009).”
Quote in the paperSubstantial claim0 of 2 sources checkedClassified as probably not a substantial claim.
InterpretationreasoningIncreased repulsive forces between MTs would generate a stronger reactive resistance against mitochondria moving inside MT bundles.
“Increased repulsive forces between MTs would generate a stronger reactive resistance against mitochondria moving inside MT bundles.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationPhosphorylation at major Ser-Pro/Thr-Pro sites reduces but does not abolish Tau binding to MTs, leading to more dynamic MTs.
“Phosphorylation at these sites reduces, but does not abolish, Tau binding to MTs, leading to more dynamic MTs (Wada et al., 1998;Liu et al., 2007).”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThis would suppress mitochondrial transport along MTs by restricting radial displacement of MTs.
“This would suppress mitochondrial transport along MTs by restricting radial displacement of MTs.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
InterpretationreasoningThe force produced by outward extension of the projection domain may not be strong enough to push surrounding MTs against the membrane, which may explain why phosphorylation-induced expansion of the inter-MT distance has not been reported.
“The force produced by outward extension of the projection domain may not be strong enough to push surrounding MTs against the membrane, which may explain why phosphorylation-induced expansion of the inter-MT distance has not been reported.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAT8 reactivity has been frequently used as an indicator of hyperphosphorylation of Tau in AD brains or other tauopathies.
“AT8 reactivity has been frequently used as an indicator of hyperphosphorylation of Tau in AD brains or other tauopathies (Stoothoff and Johnson, 2005;Hanger et al., 2009).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Stoothoff and Johnson, 2005
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Hanger et al., 2009 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll experiments were performed at least three times.
“All experiments were performed at least three times, and representative results are shown.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAccording to the paperclip structural model, the site near Ser199/Ser202/Thr205 folds and the N-terminal region is situated close to the MT-binding repeats.
“According to the paperclip structural model of Tau (Jeganathan et al., 2006), the site near Ser199/Ser202/Thr205 folds and the N-terminal region is situated close to the MT-binding repeats.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Jeganathan et al., 2006 source
Probably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing), S4 (based).
PremisecitationTau impairs mitochondrial movement by inhibiting the interaction of kinesin with microtubules.
“Tau impairs mitochondrial movement by inhibiting the interaction of kinesin with MTs (Hagiwara et al., 1994).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hagiwara et al., 1994 source
May combine two claims.
Interpretationown dataIncreased phosphorylation of the AT8 sites in brains of Alzheimer's patients decreases mitochondrial transport in axons, leading to axonal degeneration.
“Thus, our results suggest that the increased phosphorylation of the AT8 sites in brains of Alzheimer's patients decreases mitochondrial transport in axons, leading to axonal degeneration.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationTau is a phosphoprotein whose functions can be regulated by phosphorylation.
“Tau is also a phosphoprotein, the functions of which can be regulated by phosphorylation (Stoothoff and Johnson, 2005;Hanger et al., 2009).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Stoothoff and Johnson, 2005
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Hanger et al., 2009 source
May combine two claims.
Interpretationown dataPhosphorylation of Tau at the AT8 sites tends to increase the inter-MT distance, but under strong tension the inter-MT distance cannot expand, and instead the repulsive forces between MTs increase.
“Phosphorylation of Tau at the AT8 sites tends to increase the inter-MT distance, but under strong tension the inter-MT distance cannot expand (Fig. 8), and instead the repulsive forces between MTs increase (Fig. 9).”
Quote in the paperSubstantial claim
The paper relies on this without support.
Findings from cultured cells and overexpression of Tau mutants generalize to Alzheimer's disease pathophysiology.
“Hyperphosphorylation of the AT8 sites may contribute to axonal degeneration by disrupting mitochondrial transport in Alzheimer's disease.”
The paper relies on this without support.
Disrupted mitochondrial transport causes axonal degeneration.
“Hyperphosphorylation of the AT8 sites may contribute to axonal degeneration by disrupting mitochondrial transport in Alzheimer's disease.”
The paper relies on this without support.
Increased inter-microtubule spacing impairs mitochondrial transport.
“we would like to propose that phosphorylation of Tau at the AT8 sites affects the transport of mitochondria along MTs by changing the inter-MT spaces.”
The paper relies on this without support.
Site-specific functions of Tau phosphorylation have not been completely investigated.
“However, site-specific functions have not been completely investigated.”
The paper relies on this without support.
Actin filaments are abundant in submembranous regions, providing tension to plasma membranes.
“Actin filaments are abundant in submembranous regions, providing tension to plasma membranes.”
The paper relies on this without support.
The Ser199/Ser202/Thr205 sites are present in the border between the N-terminal projection region and the MT-binding region.
“The Ser199/Ser202/Thr205 sites are present in the border between the N-terminal projection region and the MT-binding region.”
Cites
Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer’s Disease
Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams, D. S., et al. (2005) · Science · doi:10.1126/science.1105681 · Cited by 1,214 · see citing works
The axonal transport of mitochondria
Saxton, W. M., & Hollenbeck, P. J. (2012) · Journal of Cell Science · doi:10.1242/jcs.053850 · Cited by 1,198 · see citing works
Phosphate-binding Tag, a New Tool to Visualize Phosphorylated Proteins
Kinoshita, E., Kinoshita‐Kikuta, E., Takiyama, K., & Koike, T. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t500024-mcp200 · Cited by 1,105 · see citing works
Differential Regulation of Dynein and Kinesin Motor Proteins by Tau
Dixit, R., Ross, J. L., Goldman, Y. E., & Holzbaur, E. L. F. (2008) · Science · doi:10.1126/science.1152993 · Cited by 1,012 · see citing works
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Hanger, D. P., Anderton, B. H., & Noble, W. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.003 · Cited by 965 · see citing works
Stamer, K., Vogel, R., Thies, E., Mandelkow, E., & Mandelkow, E.-M. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108057 · Cited by 885 · see citing works
Ebneth, A., Godemann, R., Stamer, K., Illenberger, S., Trinczek, B., Mandelkow, E.-M., & Mandelkow, E. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.3.777 · Cited by 820 · see citing works
The axonal transport of mitochondria
Hollenbeck, P. J., & Saxton, W. M. (2005) · Journal of Cell Science · doi:10.1242/jcs.02745 · Cited by 771 · see citing works
Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
Goedert, M., Jakes, R., & Vanmechelen, E. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11484-e · Cited by 608 · see citing works
Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons
Chen, J., Kanai, Y., Cowan, N. J., & Hirokawa, N. (1992) · Nature · doi:10.1038/360674a0 · Cited by 601 · see citing works
Proline-directed and non-proline-directed phosphorylation of PHF-tau
Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Yoshida, H., Titani, K., & Ihara, Y. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.823 · Cited by 557 · see citing works
Self-citationTau Reduction Prevents Aβ-Induced Defects in Axonal Transport
Vossel, K. A., Zhang, K., Brodbeck, J., Daub, A. C., Sharma, P., Finkbeiner, S., Cui, B., & Mucke, L. (2010) · Science · doi:10.1126/science.1194653 · Cited by 486 · see citing works
Multiple-motor based transport and its regulation by Tau
Vershinin, M., Carter, B. C., Razafsky, D. S., King, S. J., & Gross, S. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607919104 · Cited by 457 · see citing works
Tau phosphorylation: physiological and pathological consequences
Stoothoff, W. H., & Johnson, G. V. W. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.017 · Cited by 439 · see citing works
Global Hairpin Folding of Tau in Solution
Jeganathan, S., von Bergen, M., Brutlach, H., Steinhoff, H.-J., & Mandelkow, E. (2006) · Biochemistry · doi:10.1021/bi0521543 · Cited by 432 · see citing works
Kanai, Y., Takemura, R., Oshima, T., Mori, H., Ihara, Y., Yanagisawa, M., Masaki, T., & Hirokawa, N. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.109.3.1173 · Cited by 360 · see citing works
Trinczek, B., Ebneth, A., Mandelkow, E.-M., & Mandelkow, E. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.14.2355 · Cited by 344 · see citing works
The Roles of Cyclin-dependent Kinase 5 and Glycogen Synthase Kinase 3 in Tau Hyperphosphorylation
Plattner, F., Angelo, M., & Giese, K. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603469200 · Cited by 340 · see citing works
Thies, E., & Mandelkow, E.-M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4674-06.2007 · Cited by 293 · see citing works
Abnormal mitochondrial dynamics and neurodegenerative diseases
Su, B., Wang, X., Zheng, L., Perry, G. L., Smith, M. A., & Zhu, X. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.09.013 · Cited by 289 · see citing works
Jeganathan, S., Hascher, A., Chinnathambi, S., Biernat, J., Mandelkow, E.-M., & Mandelkow, E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805300200 · Cited by 278 · see citing works
Ishiguro, K., Takamatsu, M., Tomizawa, K., OMORI, A., Takahashi, M., Arioka, M., Uchida, T., & Imahori, K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50102-8 · Cited by 249 · see citing works
MARK/PAR1 kinase is a regulator of microtubule-dependent transport in axons
Mandelkow, E.-M., Thies, E., Trinczek, B., Biernat, J., & Mandelkow, E. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200401085 · Cited by 236 · see citing works
In vivo phosphorylation sites in fetal and adult rat tau
Watanabe, A., Hasegawa, M., Suzuki, M., Takio, K., Morishima-Kawashima, M., Titani, K., Arai, T., Kosik, K. S., & Ihara, Y. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74447-0 · Cited by 231 · see citing works
Self-citationChanges in microtubule number and length during axon differentiation
Yu, W., & Baas, P. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-02818.1994 · Cited by 213 · see citing works
Liu, F., Li, B., Tung, E., Grundke‐Iqbal, I., Iqbal, K., & Gong, C. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05955.x · Cited by 208 · see citing works
Sudo, H., & Baas, P. W. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0048-10.2010 · Cited by 181 · see citing works
Kimura, T., Yamashita, S., Fukuda, T., Park, J., Murayama, M., Mizoroki, T., Yoshiike, Y., Sahara, N., & Takashima, A. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601917 · Cited by 144 · see citing works
Differential effect of three‐repeat and four‐repeat tau on mitochondrial axonal transport
Stoothoff, W., Jones, P. B., Spires‐Jones, T. L., Joyner, D., Chhabra, E., Bercury, K., Fan, Z., Xie, H., Bacskai, B., Edd, J., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06316.x · Cited by 135 · see citing works
Jicha, G. A., Berenfeld, B., & Davies, P. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990315)55:6 · Cited by 123 · see citing works
Mature astrocytes in the adult human neocortex express the early neuronal marker doublecortin
Verwer, R. W. H., Sluiter, A. A., Balesar, R. A., Baayen, J. C., Noske, D. P., Dirven, C. M. F., Wouda, J., van Dam, A. M., Lucassen, P. J., & Swaab, D. F. (2007) · Brain · doi:10.1093/brain/awm264 · Cited by 118 · see citing works
Microtubule stability decreases axon elongation but not axoplasm production
Rochlin, M. W., Wickline, K. M., & Bridgman, P. C. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-10-03236.1996 · Cited by 117 · see citing works
Hagiwara, H., Yorifuji, H., Sato-Yoshitake, R., & Hirokawa, N. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41903-x · Cited by 115 · see citing works
Pseudo-phosphorylation of tau at Ser202 and Thr205 affects tau filament formation
Rankin, C. A., Sun, Q., & Gamblin, T. C. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.04.012 · Cited by 95 · see citing works
Mukhopadhyay, R., & Hoh, J. H. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02844-7 · Cited by 95 · see citing works
Role of tau phosphorylation by glycogen synthase kinase-3β in the regulation of organelle transport
Tatebayashi, Y., Haque, N., Tung, Y. C., Iqbal, K., & Grundke, I. (2004) · Journal of Cell Science · doi:10.1242/jcs.01018 · Cited by 92 · see citing works
Dubey, M., Chaudhury, P., Kabiru, H., & Shea, T. B. (2007) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.20243 · Cited by 91 · see citing works
The effects of dephosphorylation on the structure of the projections of neurofilament
Hisanaga, S., & Hirokawa, N. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-03-00959.1989 · Cited by 90 · see citing works
Self-citationKumar, S., Yin, X., Trapp, B. D., Hoh, J. H., & Paulaitis, M. E. (2002) · Biophysical Journal · doi:10.1016/s0006-3495(02)75581-1 · Cited by 89 · see citing works
Saito, T., Onuki, R., Fujita, Y., Kusakawa, G.-I., Ishiguro, K., Bibb, J. A., Kishimoto, T., & Hisanaga, S. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01189.2003 · Cited by 88 · see citing works
Self-citationTakahashi, S., Saito, T., Hisanaga, S.-I., Pant, H. C., & Kulkarni, A. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211964200 · Cited by 86 · see citing works
Self-citationMicrotubule-associated Protein-like Binding of the Kinesin-1 Tail to Microtubules
Seeger, M. A., & Rice, S. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.068247 · Cited by 86 · see citing works
Role of GSK‐3β in Alzheimer's disease pathology
Planel, E., Sun, X., & Takashima, A. (2002) · Drug Development Research · doi:10.1002/ddr.10100 · Cited by 85 · see citing works
Tuning microtubule-based transport through filamentous MAPs: the problem of dynein
Vershinin, M., Xu, J., Razafsky, D. S., King, S. J., & Gross, S. P. (2008) · Traffic · doi:10.1111/j.1600-0854.2008.00741.x · Cited by 76 · see citing works
Tau‐Induced Traffic Jams Reflect Organelles Accumulation at Points of Microtubule Polar Mismatching
Shemesh, O. A., Erez, H., Ginzburg, I., & Spira, M. E. (2007) · Traffic · doi:10.1111/j.1600-0854.2007.00695.x · Cited by 72 · see citing works
Tau Aggregation in Alzheimer's Disease: What Role for Phosphorylation?
Lippens, G., Sillen, A., Landrieu, I., Amniai, L., Sibille, N., Barbier, P., Leroy, A., Hanoulle, X., & Wieruszeski, J.-M. (2007) · Prion · doi:10.4161/pri.1.1.4055 · Cited by 68 · see citing works
Rudrabhatla, P., Grant, P., Jaffe, H., Strong, M. J., & Pant, H. C. (2010) · The FASEB Journal · doi:10.1096/fj.10-157859 · Cited by 65 · see citing works
Effects of endogenous β‐amyloid overproduction on tau phosphorylation in cell culture
Wang, Z., Li, H., Li, X., Zhang, Q., Tian, Q., Wang, Q., Xu, H., & Wang, J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03956.x · Cited by 65 · see citing works
Bereiter‐Hahn, J., & Jendrach, M. (2010) · International review of cytology · doi:10.1016/s1937-6448(10)84001-8 · Cited by 64 · see citing works
Microtubules in mouse embryo fibro blasts extracted with Triton X-100
Bershadsky, A. D., Gelfand, V. I., SVITKINA, T., & Tint, I. S. (1978) · Cell Biology International Reports · doi:10.1016/0309-1651(78)90093-0 · Cited by 62 · see citing works
Wada, Y., Ishiguro, K., Itoh, T. J., Uchida, T., Hotani, H., Saito, T., Kishimoto, T., & Hisanaga, S.-I. (1998) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022174 · Cited by 58 · see citing works
Self-citationTokuoka, H., Saito, T., Yorifuji, H., Wei, F., Kishimoto, T., & Hisanaga, S. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.6.1059 · Cited by 58 · see citing works
Self-citationHosokawa, T., Saito, T., Asada, A., Fukunaga, K., & Hisanaga, S. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900578-mcp200 · Cited by 57 · see citing works
Self-citationτ Regulation of Microtubule‐Microtubule Spacing and Bundling
Frappier, T. F., Georgieff, I. S., Brown, K., & Shelanski, M. L. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062288.x · Cited by 53 · see citing works
Interaction of kinesin motors, microtubules, and MAPs
Marx, A., MÜLLER, J., Mandelkow, E.-M., Hoenger, A., & Mandelkow, E.-M. (2005) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-005-9051-4 · Cited by 49 · see citing works
Darios, F. D., Muriel, M., Escobar-Khondiker, M., Brice, A., & Ruberg, M. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0060-05.2005 · Cited by 48 · see citing works
Kaminosono, S., Saito, T., Oyama, F., Ohshima, T., Asada, A., Nagai, Y., Nukina, N., & Hisanaga, S.-I. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0973-08.2008 · Cited by 46 · see citing works
Self-citationMorel, M., Authelet, M., Dedecker, R., & Brion, J. P. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.02.077 · Cited by 46 · see citing works
Diffusion and Directed Movement
Furuta, K., Edamatsu, M., Maeda, Y., & Toyoshima, Y. Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803730200 · Cited by 43 · cited 1× · see citing works
“Kinesin RK430-AviTag-KRC-His6 was expressed and purified from E. coli as described (Furuta et al., 2008), except that ATP was not added to the preparation buffers.”
MethodSelf-citationPhosphorylation of FTDP-17 Mutant tau by Cyclin-dependent Kinase 5 Complexed with p35, p25, or p39
Sakaue, F., Saito, T., Satō, Y., Asada, A., Ishiguro, K., Hasegawa, M., & Hisanaga, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504792200 · Cited by 41 · see citing works
Self-citationOrganization of actin and microtubules during process formation in tau‐expressing sf9 cells
Knowles, R. B., Leclerc, N. M., & Kosik, K. S. (1994) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.970280308 · Cited by 35 · see citing works
Morphological and biochemical changes of neurofilaments in aged rat sciatic nerve axons
Uchida, A., Tashiro, T., Komiya, Y., Yorifuji, H., Kishimoto, T., & Hisanaga, S. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02201.x · Cited by 28 · see citing works
Self-citationEndo, R., Saito, T., Asada, A., Kawahara, H., Ohshima, T., & Hisanaga, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.026443 · Cited by 27 · see citing works
Self-citation(2000) · PubMed · Cited by 23 · see citing works
A possible mechanism for controlling processive transport by microtubule-associated proteins
Shahpasand, K., Ahmadian, S., & Riazi, G. H. (2008) · Neuroscience Research · doi:10.1016/j.neures.2008.04.010 · Cited by 6 · see citing works
Self-citationDeregulation of Cytoskeletal Protein Phosphorylation and Neurodegeneration
Kanungo, J., Zheng, Y.-L., Rudrabhatla, P., Amin, N. D., Mishra, B., & Pant, H. C. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-6787-9_14 · Cited by 4 · see citing works
P3-232 Phosphorylation of FTDP-17 tau mutants by cyclin-dependent kinase 5
Sakaue, F., Hasegawa, M., Ishiguro, K., Asada, A., Saito, T., & Hisanaga, S.-I. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(04)81382-4
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Synaptic Energy Use and Supply
Harris, J. J., Jolivet, R., & Attwell, D. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.019 · Cited by 1,747 · see citing works
Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: Recent advances.
Wang, W., Zhao, F., Ma, X., Perry, G., & Zhu, X. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00376-6 · Cited by 1,274 · see citing works
Mitochondrial Defects and Oxidative Stress in Alzheimer Disease and Parkinson Disease
Yan, M. H., Wang, X., & Zhu, X. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.11.014 · Cited by 718 · see citing works
Mitochondria at the neuronal presynapse in health and disease
Devine, M. J., & Kittler, J. T. (2018) · Nature reviews. Neuroscience · doi:10.1038/nrn.2017.170 · Cited by 615 · see citing works
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
Tu, S., Okamoto, S., Lipton, S. A., & Xu, H. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-48 · Cited by 582 · see citing works
The importance of tau phosphorylation for neurodegenerative diseases
Noble, W., Hanger, D. P., Miller, C. C. J., & Lovestone, S. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00083 · Cited by 475 · see citing works
Deciphering the mechanism underlying late-onset Alzheimer disease
Krstic, D., & Knuesel, I. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.236 · Cited by 457 · see citing works
Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy
Kondo, A., Shahpasand, K., Mannix, R., Qiu, J., Moncaster, J., Chen, C.-H., Yao, Y., Lin, Y.-M., Driver, J. A., Sun, Y., et al. (2015) · Nature · doi:10.1038/nature14658 · Cited by 445 · see citing works
Self-citationPathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier
Tryphena, K. P., Shukla, R., Khatri, D. K., & Vora, L. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102481 · Cited by 418 · see citing works
Microtubule-Associated Proteins: Structuring the Cytoskeleton
Bodakuntla, S., Jijumon, A. S., Villablanca, C., González-Billault, C. E., & Janke, C. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.07.004 · Cited by 366 · see citing works
Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer’s Disease
Cai, Q., & Tammineni, P. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160726 · Cited by 274 · see citing works
Disease-associated tau impairs mitophagy by inhibiting Parkin translocation to mitochondria
Cummins, N., Tweedie, A., Zuryn, S., Bertran‐Gonzalez, J., & Götz, J. (2019) · The EMBO Journal · doi:10.15252/embj.201899360 · Cited by 267 · see citing works
Protein phosphorylation in neurodegeneration: friend or foe?
Tenreiro, S., Eckermann, K., & Outeiro, T. F. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00042 · Cited by 252 · see citing works
Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases
Gao, J., Wang, L., Liu, J., Xie, F., Su, B., & Wang, X. (2017) · Antioxidants · doi:10.3390/antiox6020025 · Cited by 250 · see citing works
Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease
Overk, C. R., & Masliah, E. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.015 · Cited by 242 · see citing works
The Association of Tau With Mitochondrial Dysfunction in Alzheimer’s Disease
Cheng, Y., & Bai, F. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00163 · Cited by 239 · see citing works
Mitochondrial Dysfunction as a Driver of Cognitive Impairment in Alzheimer’s Disease
Sharma, C., Kim, S., Nam, Y., Jung, U. J., & Kim, S. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094850 · Cited by 242 · see citing works
A role for tau at the synapse in Alzheimer’s disease pathogenesis
Pooler, A. M., Noble, W., & Hanger, D. P. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.018 · Cited by 203 · see citing works
Mitochondrial dynamics and transport in Alzheimer's disease
Flannery, P. J., & Trushina, E. V. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.06.009 · Cited by 198 · see citing works
Tapia‐Rojas, C., Cabezas-Opazo, F., Deaton, C. A., Vergara, E. H., Johnson, G. V. W., & Quintanilla, R. A. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.005 · Cited by 195 · see citing works
Cigarette smoke-induced mitochondrial fragmentation and dysfunction in human airway smooth muscle
Aravamudan, B., Kiel, A., Freeman, M., Delmotte, P., Thompson, M., Vassallo, R., Sieck, G. C., Pabelick, C. M., & Prakash, Y. S. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00155.2013 · Cited by 192 · see citing works
Barten, D. M., Fanara, P., Andorfer, C. A., Hoque, N., Wong, P. A., Husted, K. H., Cadelina, G. W., DeCarr, L. B., Yang, L., Liu, V., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0188-12.2012 · Cited by 173 · see citing works
Barone, E., Domenico, F. D., Perluigi, M., & Butterfield, D. (2021) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2021.09.006 · Cited by 155 · see citing works
Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β
Vossel, K. A., Xu, J. C., Fomenko, V., Miyamoto, T., Suberbielle, E., Knox, J. A., Ho, K., Kim, D. H., Yu, G.-Q., & Mucke, L. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201407065 · Cited by 167 · see citing works
Why size matters – balancing mitochondrial dynamics in Alzheimer's disease
DuBoff, B., Feany, M. Β., & Götz, J. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.03.002 · Cited by 164 · see citing works
Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria
Gowda, P., Reddy, P. H., & Kumar, S. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101529 · Cited by 166 · see citing works
Merkwirth, C., Martinelli, P., Korwitz, A., Morbin, M., Brönneke, H. S., Jordan, S. D., Rugarli, E. I., & Langer, T. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003021 · Cited by 162 · see citing works
Activation of mTOR: a culprit of Alzheimer&rsquo;s disease?
Cai, Z., Zhou, Y., Xiao, M., Yan, L.-J., & He, W. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75717 · Cited by 161 · see citing works
Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration
Maria Jose Perez, J., Jara, C., & Quintanilla, R. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00441 · Cited by 153 · see citing works
Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer’s Disease
Cabezas-Opazo, F., Vergara-Pulgar, K., Maria Jose Perez, J., Jara, C., Osorio‐Fuentealba, C., & Quintanilla, R. A. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/509654 · Cited by 148 · see citing works
Katsumoto, A., Takeuchi, H., & Tanaka, F. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00980 · Cited by 145 · see citing works
Synapses: The Brain’s Energy-Demanding Sites
Faria‐Pereira, A., & Morais, V. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073627 · Cited by 145 · see citing works
Tau pathology in neurodegenerative disease: disease mechanisms and therapeutic avenues
Samudra, N. P., Lane‐Donovan, C., VandeVrede, L. A., & Boxer, A. L. (2023) · Journal of Clinical Investigation · doi:10.1172/jci168553 · Cited by 135 · see citing works
Cavallini, A., Brewerton, S., Bell, A., Sargent, S., Glover, S., Hardy, C., Moore, R., Calley, J., Ramachandran, D., Poidinger, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.463984 · Cited by 133 · see citing works
“It has been suggested that hyperphosphorylation of tau may contribute to axonal degeneration by disrupting mitochondrial transport in AD (36).”
BackgroundEckert, A., Nisbet, R. M., Grimm, A., & Götz, J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.013 · Cited by 127 · see citing works
Cieri, D., Vicario, M., Vallese, F., D’Orsi, B., Berto, P., Grinzato, A., Catoni, C., Stefani, D. D., Rizzuto, R., Brini, M., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.07.011 · Cited by 122 · see citing works
Phospho-Tau Bar Code: Analysis of Phosphoisotypes of Tau and Its Application to Tauopathy
Kimura, T., Sharma, G., Ishiguro, K., & Hisanaga, S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00044 · Cited by 112 · see citing works
Self-citationYang, D., Ying, J., Wang, X., Zhao, T., Yoon, S., Yang, F., Zheng, Q., Liu, X., Yu, W., & Hua, F. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.654785 · Cited by 110 · see citing works
Klein, H., Trumpff, C., Yang, H., Lee, A., Picard, M. A., Bennett, D. A., & Jager, P. L. D. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00495-8 · Cited by 110 · see citing works
Bernardo, T. C., Marques‐Aleixo, I., Beleza, J., Oliveira, P. J., Ascensão, A., & Magalhães, J. (2016) · Brain Pathology · doi:10.1111/bpa.12403 · Cited by 108 · see citing works
Peng, Y., Gao, P., Shi, L., Chen, L., Liu, J., & Long, J. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7763 · Cited by 110 · see citing works
Nery, L. R., Eltz, N. S., Hackman, C., Fonseca, R. S., Altenhofen, S., Guerra, H. N., Freitas, V. M., Bonan, C. D., & Vianna, M. R. M. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105862 · Cited by 106 · see citing works
Insights into Disease-Associated Tau Impact on Mitochondria
Szabo, L., Eckert, A., & Grimm, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176344 · Cited by 102 · see citing works
Torres, M., Jiménez, S., Sanchez-Varo, R. M., Navarro, V., Trujillo‐Estrada, L., Sánchez‐Mejías, E., Carmona, I., Dávila, J. C., Vizuete, M., Gutiérrez, A., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-59 · Cited by 103 · see citing works
Duka, V., Lee, J., Credle, J. J., Wills, J., Oaks, A. W., Smolinsky, C., Shah, K., Mash, D. C., Masliah, E., & Sidhu, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075025 · Cited by 102 · see citing works
RetractedZhu, H., Zhang, W., Zhao, Y., Shu, X., Wang, W., Wang, D., Yang, Y., He, Z., Wang, X., & Ying, Y. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0295-z · Cited by 99 · see citing works
Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy
Caillet‐Boudin, M., Fernández-Gómez, F.-J., Tran, H., Dhaenens, C., Buée, L., & Sergeant, N. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00057 · Cited by 99 · see citing works
Mitochondrial Behavior in Axon Degeneration and Regeneration
Wang, B., Huang, M., Shang, D., Yan, X., Zhao, B., & Zhang, X. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.650038 · Cited by 90 · see citing works
Cantuti‐Castelvetri, L., Givogri, M. I., Hebert, A., Smith, B., Song, Y., Kamińska, A., Lopez‐Rosas, A., Morfini, G. A., Pigino, G. F., Sands, M. S., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0217-13.2013 · Cited by 88 · see citing works
Tau-induced neurodegeneration: mechanisms and targets
Beharry, C., Cohen, L. S., Di, J., Ibrahim, K., Briffa-Mirabella, S., & Alonso, A. D. C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1414-z · Cited by 88 · see citing works
Mitochondrial traffic jams in Alzheimer's disease - pinpointing the roadblocks
Correia, S. C., Perry, G. L., & Moreira, P. I. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.07.010 · Cited by 88 · see citing works
Mitochondrial Dysfunction in Neurodegenerative Diseases
Yang, H. (2025) · Cells · doi:10.3390/cells14040276 · Cited by 92 · see citing works
Stefanova, N. A., Maksimova, K. Y., Владимировна, К. Е., Rudnitskaya, E. A., Muraleva, N. A., & Kolosova, N. G. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12248 · Cited by 84 · see citing works
Stephan, R., Goellner, B., Moreno, E., Frank, C. A., Hugenschmidt, T., Genoud, C., Aberle, H., & Pielage, J. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.02.003 · Cited by 85 · see citing works
Kondadi, A. K., Wang, S., Montagner, S., Kladt, N., Korwitz, A., Martinelli, P., Herholz, D., Baker, M. J., Schauss, A. C., Langer, T., et al. (2014) · The EMBO Journal · doi:10.1002/embj.201387009 · Cited by 81 · see citing works
Releasing the brake: restoring fast axonal transport in neurodegenerative disorders
Hinckelmann, M.-V., Zala, D., & Saudou, F. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.08.007 · Cited by 78 · see citing works
Mechanical Effects of Dynamic Binding between Tau Proteins on Microtubules during Axonal Injury
Ahmadzadeh, H., Smith, D. H., & Shenoy, V. B. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2015.09.010 · Cited by 78 · see citing works
Zhao, Y., Chen, X., Wu, Y., Wang, Y., Li, Y., & Xiang, C. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00140 · Cited by 79 · see citing works
Stefanova, N. A., Muraleva, N. A., Maksimova, K. Y., Rudnitskaya, E. A., Владимировна, К. Е., Telegina, D. V., & Kolosova, N. G. (2016) · Aging · doi:10.18632/aging.101054 · Cited by 77 · see citing works
Autophagic Pathways to Clear the Tau Aggregates in Alzheimer’s Disease
Gorantla, N. V., & Chinnathambi, S. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00897-0 · Cited by 74 · see citing works
Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer’s Disease
Torres, A. K., Jara, C., Park-Kang, H. S., Polanco, C. M., Tapia, D., Alarcón, F., de la Peña, A., Llanquinao, J., Vargas-Mardones, G., Álvarez‐Indo, J., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215139 · Cited by 79 · see citing works
Ca2+ Dyshomeostasis Disrupts Neuronal and Synaptic Function in Alzheimer’s Disease
McDaid, J., Mustaly-Kalimi, S., & Stutzmann, G. E. (2020) · Cells · doi:10.3390/cells9122655 · Cited by 73 · see citing works
Tubulin polyglutamylation is a general traffic-control mechanism in hippocampal neurons
Bodakuntla, S., Schnitzler, A., Villablanca, C., González-Billault, C. E., Bièche, I., Janke, C., & Magiera, M. M. (2020) · Journal of Cell Science · doi:10.1242/jcs.241802 · Cited by 73 · see citing works
Phosphorylated tau potentiates Aβ-induced mitochondrial damage in mature neurons
Quintanilla, R. A., Rommy von Bernhardi, M., Godoy, J. A., Inestrosa, N. C., & Johnson, G. V. W. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.016 · Cited by 72 · see citing works
Guha, S. K., Johnson, G. V. W., & Nehrke, K. W. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02084-0 · Cited by 72 · see citing works
Kimura, T., Tsutsumi, K., Taoka, M., Saito, T., Masuda‐Suzukake, M., Ishiguro, K., Plattner, F., Uchida, T., Isobe, T., Hasegawa, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.433326 · Cited by 72 · see citing works
Self-citationKulbe, J. R., & Hall, E. D. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.08.003 · Cited by 69 · see citing works
Mitochondrial dysfunction in Alzheimer's disease: Guiding the path to targeted therapies
Percy, K. C. M., Liu, Z., & Qi, X. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00525 · Cited by 67 · see citing works
Mitochondria dynamism: of shape, transport and cell migration
da Silva, A. F., Mariotti, F. R., Máximo, V., & Campello, S. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1557-8 · Cited by 67 · see citing works
Vitamin B12 Inhibits Tau Fibrillization via Binding to Cysteine Residues of Tau
Rafiee, S., Asadollahi, K., Riazi, G. H., Ahmadian, S., & Saboury, A. A. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00230 · Cited by 67 · see citing works
Lopes, S., Teplytska, L., Vaz-Silva, J., Dioli, C., Trindade, R., Morais, M., Webhofer, C., Maccarrone, G., Almeida, O. F. X., Turck, C. W., et al. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw057 · Cited by 66 · see citing works
Reassessment of Pioglitazone for Alzheimer’s Disease
Saunders, A. M., Burns, D. K., & Gottschalk, W. K. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.666958 · Cited by 67 · see citing works
Role of Impaired Mitochondrial Dynamics Processes in the Pathogenesis of Alzheimer’s Disease
Blagov, A. V., Grechko, A. V., Nikiforov, N. G., Borisov, E. E., Sadykhov, N. K., & Orekhov, A. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23136954 · Cited by 65 · see citing works
A Tale of the Good and Bad: Remodeling of the Microtubule Network in the Brain by Cdk5
Shah, K., & Lahiri, D. K. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9792-7 · Cited by 67 · see citing works
Vagnoni, A., Hoffmann, P. C., & Bullock, S. L. (2015) · Journal of Cell Science · doi:10.1242/jcs.179184 · Cited by 65 · see citing works
The meaning of mitochondrial movement to a neuron's life
Lovas, J. R., & Wang, X. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.04.007 · Cited by 62 · see citing works
Stathas, S., Alvarez, V. E., Xia, W., Nicks, R., Meng, G., Daley, S. A., Pothast, M. J., Shah, A., Kelley, H. J., Esnault, C. D., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12502 · Cited by 62 · see citing works
Lacombe, A., & Scorrano, L. (2024) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2024.02.001 · Cited by 64 · see citing works
Tubulin Post-Translational Modifications: The Elusive Roles of Acetylation
Carmona, B., Marinho, H. S., Matos, C. L., Nolasco, S., & Soares, H. (2023) · Biology · doi:10.3390/biology12040561 · Cited by 58 · see citing works
Onishi, T., Maeda, R., Terada, M., Sato, S., Fujii, T., Ito, M., Hashikami, K., Kawamoto, T., & Tanaka, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-94923-w · Cited by 58 · see citing works
The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection
Quntanilla, R. A., & Tapia-Monsalves, C. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200525020259 · Cited by 59 · see citing works
Quintanilla, R. A., Tapia-Monsalves, C., Vergara, E. H., Maria Jose Perez, J., & Aránguiz, A. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00175 · Cited by 53 · see citing works
Ying, Y., Zhang, Y., Ma, C., Li, M., Tang, C.-Y., Yang, Y.-F., Zeng, J., Huang, X., Yi, J., Wang, X., et al. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b02954 · Cited by 51 · see citing works
Shu, X., Zhang, Y., Li, M., Huang, X., Yang, Y., Zeng, J., Zhao, Y., Wang, X., Zhang, W., & Ying, Y. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.04.018 · Cited by 51 · see citing works
Vacchi, E., Kaelin‐Lang, A., & Melli, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145030 · Cited by 50 · see citing works
Petrozziello, T., Bordt, E. A., Mills, A. N., Kim, S. E., Sapp, E., Devlin, B. A., Obeng-Marnu, A. A., Farhan, S. M. K., Amaral, A. C. S., Dujardin, S., et al. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02557-w · Cited by 49 · see citing works
Tapia‐Rojas, C., Torres, A., Rivera, B., Polanco, C. M., & Jara, C. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.332125 · Cited by 46 · see citing works
Tuerde, D., Kimura, T., Miyasaka, T., Furusawa, K., Shimozawa, A., Hasegawa, M., Ando, K., & Hisanaga, S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.798918 · Cited by 47 · see citing works
Self-citationLiu, X., Ye, M., & Ma, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1022821 · Cited by 48 · see citing works
To target Tau pathologies, we must embrace and reconstruct their complexities
Limorenko, G., & Lashuel, H. A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105536 · Cited by 39 · see citing works
Sang, C., Philbert, S. A., Hartland, D., Unwin, R. D., Dowsey, A. W., Xu, J., & Cooper, G. J. S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.893159 · Cited by 40 · see citing works
Chen, Y., Han, S., Huang, X., Ni, J., & He, X. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020163 · Cited by 39 · see citing works
Matamoros‐Angles, A., Gayosso, M., Richaud‐Patín, Y., di Domenico, A., Vergara, C., Hervera, A., Sousa, A., Fernández‐Borges, N., Consiglio, A., Gavı́n, R., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0506-6 · Cited by 37 · see citing works
Ghalandari, B., Asadollahi, K., Shakeri‐Zadeh, A., Komeili, A., Riazi, G. H., Kamrava, S. K., & Attaran, N. (2019) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2019.01.012 · Cited by 39 · see citing works
Shaw, J. L., & Chang, K. T. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003792 · Cited by 38 · see citing works
Li, X., Wu, Z., Si, X., Li, J., Wu, G., & Wang, M. (2025) · European journal of medical research · doi:10.1186/s40001-025-02699-w · Cited by 42 · see citing works
LMTK1 regulates dendritic formation by regulating movement of Rab11A-positive endosomes
Takano, T., Urushibara, T., Yoshioka, N., Saito, T., Fukuda, M., Tomomura, M., & Hisanaga, S. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-01-0675 · Cited by 37 · see citing works
Self-citationNmnat2 Attenuates Tau Phosphorylation Through Activation of PP2A
Cheng, X., Zhao, K.-P., Jiang, X., Du, L., Li, X., Ma, Z., Yao, J., Luo, Y., Duan, D.-X., Wang, J., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122173 · Cited by 37 · see citing works
Human dermal fibroblasts in psychiatry research
Kalman, J. L., Garbett, K. A., Janka, Z., & Mirnics, K. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.01.067 · Cited by 38 · see citing works
Hori, T., Eguchi, K., Wang, H.-Y., Miyasaka, T., Guillaud, L., Taoufiq, Z., Mahapatra, S., Yamada, H., Takei, K., & Takahashi, T. (2022) · eLife · doi:10.7554/elife.73542 · Cited by 34 · see citing works
- Authors
- Shahpasand, K., Uemura, I., Saito, T., Asano, T., Hata, K., Shibata, K., Toyoshima, Y., Hasegawa, M., & Hisanaga, S.-I.
- Affiliations
- Tokyo Metropolitan University (JP)
- The University of Tokyo (JP)
- Tokyo Metropolitan Institute of Medical Science (JP)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2012-02-14
- Volume
- 32
- Issue
- 7
- Pages
- 2430-2441
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6621814
- OpenAlex
- W2075421841
- Semantic Scholar
- a4791d1257573d035e515b969027264b27c9b2a9
- Cited by
- 206
- References
- 67
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 11 · 2023: 18 · 2022: 15 · 2021: 23 · 2020: 16 · 2019: 10 · 2018: 12 · 2017: 9 · 2016: 15 · 2015: 15 · 2014: 16 · 2013: 12 · 2012: 8
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science (23240050)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- tau phosphorylation, Alzheimer's disease, mitochondrial transport, neurofibrillary tangles, axonal degeneration, phosphomimetic mutations, PC12 cells, cortical neurons, axonal mitochondria
- MeSH terms
- Alanine, Alzheimer Disease, Animals, Aspartic Acid, Biological Transport, Cells, Cultured, Chlorocebus aethiops, Female, Humans, Male, Microtubules, Mitochondria, Mutation, Phosphorylation, Protein Binding, PC12 Cells, tau Proteins, COS Cells, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-11-02.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-11-02.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review